Manufacturer
Unique Pharma Lab
Contents
Diclofenac Na
Indication
Acute & chronic symptomatic treatment of RA, OA & ankylosing spondylitis.
Instruction
Should be taken on an empty stomach: Swallow whole, do not divide/chew.
Drug interaction
Increased plasma conc & decreased elimination of lithium. Exacerbated cardiac failure, reduced GFR & increased plasma glycoside levels w/ cardiac glycosides. Enhanced effects of anticoagulant eg, warfarin. Hyperglycaemic & hypoglycaemic effects w/ oral antidiabetic agents. Increased nephrotoxicity w/ ciclosporin & tacrolimus. Reduced mifepristone effect. Increased toxicity of methotrexate. Increased risk of convulsions associated w/ quinolone antibiotics. Increased frequency of side effects w/ other systemic NSAIDs (eg, aspirin). Increased risk of GI bleeding w/ corticosteroids. Increased risk of nephrotoxicity by diuretics. Reduced effect of antihypertensives.
Malaysia
